Additionally, patients may be categorized as either symptomatic, where patients are aware of hypoglycemic events, and hypo-unaware, where patients do not have noticeable symptoms and are unaware of their hypoglycemic event
At present, the BC case has yet to reach the certification hearing stage, where the court determines whether the action can properly be pursued as a class action
Semaglutide (the active ingredient in Wegovy) binds to GLP-1 receptors in the brain and pancreas, triggering feelings of fullness, reducing hunger hormones, and improving blood sugar control
Most Rybelsus side effects, particularly digestive issues like nausea, are most pronounced during the first 4-8 weeks as your body adjusts to the medication